Fred Alger Management, LLC Neogenomics Inc Transaction History
Fred Alger Management, LLC
- $19.7 Billion
- Q4 2024
A detailed history of Fred Alger Management, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 1,712,959 shares of NEO stock, worth $21.3 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,712,959
Previous 1,782,897
3.92%
Holding current value
$21.3 Million
Previous $26.3 Million
7.35%
% of portfolio
0.14%
Previous 0.13%
Shares
24 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$244 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$177 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$81 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$76.5 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$76.4 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.56B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...